A decision to proceed with nasal polyp surgery was recorded in just 0.5% of tezepelumab-treated patients compared to 22.1% in ...

significantly reducing nasal polyp size, nasal congestion severity, and the need for systemic corticosteroids and/or surgery. Rapid take-up of Dupixent in atopic dermatitis and asthma caused sales ...

A new CT-scan-based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due ... protrusions, or polyps, block the nasal and sinus cavities.

Researchers have developed and preliminarily tested a composite score that simultaneously assesses the severity of asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) in patients with both ...

The drug improved both the size of nasal polyps at week 52 and in nasal obstruction during weeks 49-52, compared to placebo when added to standard of care, and extended the time to surgery by 57%.

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due ... protrusions, or polyps, block the nasal and sinus cavities.